Meet the team

Our team has a long experience from pharmaceutical research and development, business development, entrepreneurship, transplantation surgery and immunology. We are located across two continents covering the global operations.

Aeisha Wallace

Director, Project Management

Christopher Zergebel

Vice President, Head of Operations and Program Management

Alan Slade

Senior VP, Global Head Clinical Development

Alexandra Ingman

TMF Associate

Anna-Karin Lindblad

Financial Controller

Benedetta Maria Sala

Research Scientist

Britain Javens

Clinical Trial Manager

Chase Schertzinger

Clinical Research Associate

Desiree Shrode

Associate Human Resources Director & Executive Assistant

David Berglund

Founder & President

Jennifer Sutkus

Senior Manager, Quality and Regulatory Systems

Elina Tusach Chacana

Workplace Coordinator

Elizabeth Boelter

Clinical Research Associate

Elma Redzic

Associate Clinical Trial Manager

Erik Berglund

CEO & Founder

Filip Cvetkovski

Laboratory Director Research and Development

Fredrik Juhlin

Clinical Operations Director

Gemma Hodgson

Senior Clinical Trial Associate

Jesse Scott

Clinical Trial Manager

Karin Sewerin

Strategic Chemistry Manufacturing and Controls Advisor

Kasper Granlund

Chief Financial Officer

Katelyn Mulligan

Associate Director, Regulatory Affairs

Kellie Kennon

Executive Director, Head of Clinical Operations

Leslie Zacks

Chief Legal and Compliance Officer

Lindsey Dickerson

Clinical Trial Associate

Lovisa Ringstad

Global CMC Regulatory Affairs, Associate Director

Malin Robin

VP, Head of Quality Assurance

Marsha Miller

VP, Head of Regulatory Affairs

Mikael Holmqvist

Head of IT

Miriam Casacuberta-Partal

Clinical Trial Associate

Pallavi Purohit

Senior Clinical Trial Associate

Nick Hryciw

Associate Director

Paul Reiss

Director, Project Management

Peter Frank

Head of CMC

Sara Lavasani

Clinical Trial Manager

Stefan Berg

Head of Supply Chain Management & Logistics and Founder

Susanne Svärd

HR & Workplace Manager

Terese Bylund

Accountant

Help us make a real difference

We’re developing an innovative therapy that would potentially empower transplant patients to reclaim their freedom and quality of life – all without the need for immunosuppressive medications.